Kikuchi Disease: Recognizing a Common Presentation of an Uncommon Condition by Punati, MD, Ramya
The Medicine Forum
Volume 17 Article 17
Kikuchi Disease: Recognizing a Common
Presentation of an Uncommon Condition
Ramya Punati, MD
Thomas Jefferson University, ramya.punati@jefferson.edu
Follow this and additional works at: http://jdc.jefferson.edu/tmf
Part of the Internal Medicine Commons
Let us know how access to this document benefits you
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
The Medicine Forum by an authorized administrator of the Jefferson Digital Commons. For more information, please contact:
JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Punati, MD, Ramya () "Kikuchi Disease: Recognizing a Common Presentation of an Uncommon Condition," The Medicine Forum:
Vol. 17, Article 17.
Available at: http://jdc.jefferson.edu/tmf/vol17/iss1/17
36   |   The Medicine Forum, Volume 17     5
(ALT) within one week. Abdominal ultrasound showed 
increased echogenicity of the portal triads consistent 
with hepatitis.  Her ferritin level was initially elevated at 
1379 ng/mL and peaked at 16394 ng/mL one week after 
admission. Her triglyceride level was normal. 
Inflammatory markers, namely erythrocyte sedimentation 
rate and C-reactive protein levels were moderately 
elevated. Complete autoimmune workup was negative 
except for anti-smooth-muscle antibody which was 
positive at a low titer (1:40) and anti-Smith/RNP antibody 
which was positive at 309 U/mL. Infectious workup for 
bacterial, viral, and parasitic etiologies was negative 
except for an indeterminate interferon-γ release assay 
(QuantiFERON-TB Gold) result and Hepatitis B serologies 
consistent with prior immunization. 
In terms of hematologic and oncologic workup, labs 
were not consistent with tumor lysis syndrome. Lactate 
dehydrogenase was elevated at 1348 IU/L. Blood smear 
showed pancytopenia with left-shifted granulocytes. 
Peripheral blood flow cytometry showed a CD4:CD8 T 
lymphocyte ratio of 2.3. A bone marrow biopsy was 
performed and flow cytometry of the aspirate showed 
no phenotypically abnormal population. Molecular 
genetics confirmed normal female karyotype (46 XX). 
Pathology showed a hypocellular bone marrow (10%) 
with markedly hypoplastic trilineage hematopoiesis. 
There was also dyserythropoiesis and left-shifted 
myelopoiesis but no suggestion of malignancy or 
hemophagocytosis.  
As the above workup was carried out, the patient’s 
intermittent fevers and painful lymphadenopathy 
persisted.
DIFFERENTIAL DIAGNOSIS
The differential diagnosis was initially broad and included 
lymphoma, autoimmune conditions such as systemic 
lupus erythematosus (SLE) and hemophagocytic 
lymphohistiocytosis, and obscure infectious etiologies. 
As none of the workup was conclusive or diagnostic, an 
excisional biopsy of a right cervical lymph node was 
performed. The pathology of this lymph node showed 
extensive apoptosis and necrosis with histiocytic infiltrate 
and immunoblast proliferation, consistent with Kikuchi 
lymphadenitis. 
INTRODUCTION
Kikuchi disease, also known as histiocytic necrotizing 
lymphadenitis or Kikuchi-Fujimoto disease, is a rare 
condition that typically presents with fever and cervical 
lymphadenopathy in previously healthy young women. 
First described by Dr. Kikuchi and independently by Dr. 
Fujimoto in Japan in 1972, the disease is benign and 
usually self-limited. However, because it can present 
dramatically and mimic more serious conditions such as 
lymphoma and tuberculous adenitis, recognizing Kikuchi 
disease is crucial to avoid misdiagnosis and inappropriate 
treatment. This case describes a patient who presented 
with severe manifestations of Kikuchi disease that 
generated an extensive workup and differential diagnosis 
prior to its identification.  
CASE PRESENTATION 
A 24-year-old African-American female with no past 
medical history presented with fever of 104°F and painful 
cervical lymphadenopathy of several weeks duration. 
The patient had recently been hospitalized at two other 
hospitals with these symptoms and was treated 
empirically with amoxicillin and then doxycycline for 
presumed acute bacterial infections without 
improvement in her symptoms. At the time of admission 
to Jefferson, the patient reported persistent fevers, 
nausea, diffuse abdominal pain, twenty pound weight 
loss, frequent loose, nonbloody stools, and worsening 
lymphadenopathy which began in the cervical region 
and more recently involved the axillary and inguinal 
nodes. She had no rash, urinary symptoms, or cardiopul-
monary symptoms. She denied recent travel, sexual 
contact, or pertinent family history. On exam, she was 
ill-appearing but hemodynamically stable. Exam was 
notable for significant tender, firm lymphadenopathy in 
the cervical, submandibular, axillary, and inguinal regions 
bilaterally. Abdomen was diffusely tender but soft and 
nondistended without hepatosplenomegaly. 
Laboratory studies on admission showed pancytopenia 
(white blood cell [WBC] count 1.6 B/L with 35% bands, 
hemoglobin 9.8 g/dL, platelets 120 B/L), normal basic 
metabolic panel, and mild elevation of transaminases 
(aspartate aminotransferase [AST] 80 IU/L, alanine 
aminotransferase [ALT] 95 IU/L). She was empirically 
started on broad-spectrum antibiotics for sepsis, though 
these were discontinued after all cultures remained 
negative. CT of the chest, abdomen, and pelvis showed 
no lymphadenopathy or evidence of infection. Her 
transaminases rose to 2045 IU/L (AST) and 1068 IU/L 
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of T and B cell blasts can raise the possibility of lymphoma, 
but preservation of nodal architecture and the polyclonal 
infiltrate exclude this. Later, biopsies in the necrotizing 
phase show necrosis with progressive predominance of 
histiocytes. The lack of neutrophils in this phase helps 
distinguish it from SLE and drug-induced lymphade-
nopathy. 
Management of Kikuchi disease consists primarily of 
supportive care, as there is no proven effective treatment. 
However, patients with severe or persisting symptoms 
have been treated with glucocorticoids or intravenous 
immunoglobulin with apparent benefit.7 In most patients, 
the disease is self-limited and symptoms resolve within 
one to four months.  However, patients should be 
followed for several years for late recurrences or 
development of SLE.8 
KEY POINTS
• Kikuchi disease is rare but should be considered in the 
differential diagnosis of young females presenting with 
fever and cervical lymphadenopathy. 
• Although Kikuchi disease is self-limited and benign, 
lymph node biopsy should always be performed when 
the diagnosis is suspected to rule out more serious 
mimicking conditions that require specific, aggressive 
therapy such as lymphoma or tuberculous adenitis. 
• No effective treatment has been established for 
Kikuchi disease, although steroids have been helpful in 
many cases.
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OUTCOME AND FOLLOW-UP
The patient began treatment with high-dose intravenous 
steroids on hospital day 7. Following steroid adminis-
tration, she became afebrile and had a decrease in her 
painful lymphadenopathy with improving transaminases, 
ferritin and WBC count (Figure 1). She was discharged 
on a slow steroid taper with rheumatology and 
hematology follow-up. 
DISCUSSION 
Kikuchi disease is a rare, benign condition that usually 
presents with fever and cervical lymphadenopathy and is 
defined by its classic lymph node histopathology. Although 
originally described in Japan, the disease has since been 
found in all racial groups and various countries. It is more 
common in females than males and the mean age at 
presentation is 30 years.1 The pathogenesis is unknown, 
but evidence suggests an immune response of T cells and 
histiocytes to an infectious agent such as a herpesvirus.2 
Clinically, patients with Kikuchi disease typically present 
with lymphadenopathy and fever lasting one week to one 
month, as the patient in this case did. In the majority of 
cases, only the cervical lymph nodes are involved, and 
they are moderately enlarged (1-2 cm), firm, smooth, 
mobile, and painful.3 Rarely, patients may present with 
fever of unknown origin and have only mediastinal or 
retroperitoneal lymphadenopathy. Other common 
findings include leukopenia (43%), anemia (23%), rash 
(10%), arthritis (7%), and hepatosplenomegaly (3%).4,5 
Rashes seen in Kikuchi disease can be highly variable, 
mimicking drug eruptions or the malar rash of SLE. 
Common constitutional symptoms include night sweats, 
weight loss, myalgias, nausea, vomiting, and diarrhea. In 
addition, inflammatory conditions of various organs have 
been reported in association with Kikuchi disease, 
including aseptic meningitis, autoimmune hepatitis, 
thyroiditis, polymyositis, uveitis, and neuritis. 
The diagnosis of Kikuchi disease is made by lymph node 
biopsy, which on microscopy shows paracortical foci 
with necrosis and a histiocytic cellular infiltrate.1,6 In the 
earlier, proliferative phase of the disease, the presence 
Figure 1. Trend of white blood cell count (WBC), transaminases and ferritin during 
patient’s hospital stay. Dotted line indicates initiation of steroids on hospital day 7. 
(AST - aspartate aminotransferase; ALT - alanine aminotransferase) 
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